Investing.com - Financial Markets Worldwide

Beijing SL Pharmaceutical Co Ltd (002038)

Shenzhen
Currency in CNY
7.56
+0.15(+2.02%)
Delayed Data·
002038 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
002038 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
7.487.74
52 wk Range
5.988.71
Key Statistics
Edit
Bid/Ask
7.55 / 7.56
Prev. Close
7.41
Open
7.6
Day's Range
7.48-7.74
52 wk Range
5.98-8.71
Volume
25.58M
Average Volume (3m)
17.34M
1-Year Change
9.1%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002038 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 9
Net income is expected to grow this year
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Beijing SL Pharmaceutical Co Ltd Company Profile

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, research, develops, produces, and markets genetic engineering and related drugs in the People’s Republic of China and internationally. The company’s finished formulations includes temozolomide; arsenic trioxide; lenalidomide capsules; docetaxel; paclitaxel; recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; liraglutide; insulin aspart 30; insulin aspart 50; insulin aspart; recombinant human follitropin(rh-fsh); ciclosporin; mycophenolate mofetil dispersible; voriconazole; ornidazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; ademetionine 1,4-butanedisulfonate; glutathione; rivaroxaban; enoxaparin sodium; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; risedronate sodium; loratadine dispersible; somatostatin; octreotide acetate; calcitonin; paracetamol and tramadol hydrochloride; and etodolac. It also offers active pharmaceutical ingredients. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is headquartered in Beijing, the People’s Republic of China.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
889
Market
China

Compare 002038 to Peers and Sector

Metrics to compare
002038
Peers
Sector
Relationship
P/E Ratio
−79.2x32.6x−0.5x
PEG Ratio
0.59−0.850.00
Price/Book
1.4x2.5x2.6x
Price / LTM Sales
13.3x6.6x3.2x
Upside (Analyst Target)
-17.7%45.9%
Fair Value Upside
Unlock15.6%7.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.09%
Dividend Yield
0.27%
Industry Median 1.57%
Annualised payout
0.02
Paid annually
5-Years Growth
-36.90%
Growth Streak
Unlock

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
0.04 / --
Revenue / Forecast
168.90M / --
EPS Revisions
a
a
Unlock
Last 90 days

002038 Income Statement

FAQ

What Stock Exchange Does Sl Pharm A Trade On?

Sl Pharm A is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Sl Pharm A?

The stock symbol for Sl Pharm A is "002038."

What Is the Sl Pharm A Market Cap?

As of today, Sl Pharm A market cap is 7.73B.

What Is Sl Pharm A's Earnings Per Share (TTM)?

The Sl Pharm A EPS (TTM) is -0.09.

From a Technical Analysis Perspective, Is 002038 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sl Pharm A Stock Split?

Sl Pharm A has split 8 times.

How Many Employees Does Sl Pharm A Have?

Sl Pharm A has 889 employees.

What is the current trading status of Sl Pharm A (002038)?

As of 14 Jul 2025, Sl Pharm A (002038) is trading at a price of 7.56, with a previous close of 7.41. The stock has fluctuated within a day range of 7.48 to 7.74, while its 52-week range spans from 5.98 to 8.71.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.